Clinical Trial Update: Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase Ib/II trial evaluated the efficacy and safety of the R-CMC544/R-GEMOX combination in patients with diffuse large B-cell lymphoma at first o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-CMC544
• R-GemOx (rituximab, gemcitabine, oxaliplatin)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Diffuse Large B-Cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED